About HGHRX
Hartford Healthcare Fund is an open-end mutual fund that focuses on investments within the health care sector. Its primary objective is long-term capital appreciation, achieved by allocating at least 80% of its assets to equity securities of companies engaged in pharmaceuticals, biotechnology, medical products, medical delivery, and medical services. This fund employs a broad approach across various health-related industries, enabling wide exposure to both established and innovative firms advancing medical science and healthcare delivery. The portfolio is heavily weighted toward U.S. companies but also includes a modest allocation to international firms, capturing global healthcare trends and opportunities. The top holdings often include large-cap leaders in biotechnology, pharmaceuticals, and medical device manufacturing, reflecting a focus on sectors poised for growth due to demographic shifts, technological innovation, and worldwide healthcare demand. Hartford Healthcare Fund plays a significant role for investors seeking specialized exposure to the dynamic healthcare industry, providing diversification and access to a sector integral to both economic advancement and societal well-being.
Fund Family Hartford Mutual Funds
Category Health
Performance Rating Average
Risk Rating Average
Stock Exchange Nasdaq
Ticker Symbol HGHRX
Share Class Class R3
Index S&P Composite 1500 Health Care TR
HGHRX had a total return of 23.20% in the past year, including dividends. Since the fund's
inception, the average annual return has been 9.73%.
